MYELOPROLIFERATIVE NEOPLASM
Clinical trials for MYELOPROLIFERATIVE NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new MYELOPROLIFERATIVE NEOPLASM trials appear
Sign up with your email to follow new studies for MYELOPROLIFERATIVE NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Personalized Post-Transplant therapy aims to stop cancer return
Disease control Not yet recruitingThis study tests whether giving tailored maintenance therapy after a stem cell transplant can prevent relapse in people with myeloid cancers like leukemia or myelodysplastic syndrome. About 450 adults will be assigned to treatment based on whether tests detect leftover cancer cel…
Matched conditions: MYELOPROLIFERATIVE NEOPLASM
Phase: PHASE2 • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated May 17, 2026 02:14 UTC
-
New drug combo targets Tough-to-Treat bone marrow cancer
Disease control Not yet recruitingThis study tests a combination of two drugs, pacritinib and azacitidine, in 25 people with myelodysplastic syndrome (MDS) at moderate to very high risk. The first part finds the safest dose of pacritinib, and the second part checks how well the combo works. Researchers will also …
Matched conditions: MYELOPROLIFERATIVE NEOPLASM
Phase: PHASE1, PHASE2 • Sponsor: Thomas Jefferson University • Aim: Disease control
Last updated May 17, 2026 02:07 UTC